Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of proteomic patterns in serum to identify ovarian cancer.
Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Petricoin EF, et al. Among authors: mills gb. Lancet. 2002 Feb 16;359(9306):572-7. doi: 10.1016/S0140-6736(02)07746-2. Lancet. 2002. PMID: 11867112
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
Liotta LA, Petricoin EF 3rd, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC. Liotta LA, et al. Among authors: mills gb. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S25-8; discussion S37-42. doi: 10.1006/gyno.2002.6679. Gynecol Oncol. 2003. PMID: 12586081 Review. No abstract available.
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.
Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, Liotta LA, Petricoin EF 3rd, Wulfkuhle JD. Sheehan KM, et al. Among authors: mills gb. Mol Cell Proteomics. 2005 Apr;4(4):346-55. doi: 10.1074/mcp.T500003-MCP200. Epub 2005 Jan 25. Mol Cell Proteomics. 2005. PMID: 15671044 Free article. Review.
Molecular therapeutics: promise and challenges.
Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB. Kohn EC, et al. Among authors: mills gb. Semin Oncol. 2004 Feb;31(1 Suppl 3):39-53. doi: 10.1053/j.seminoncol.2004.01.009. Semin Oncol. 2004. PMID: 15052542 Review.
Early detection of ovarian cancer: promise and reality.
Bast RC Jr, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G. Bast RC Jr, et al. Cancer Treat Res. 2002;107:61-97. doi: 10.1007/978-1-4757-3587-1_3. Cancer Treat Res. 2002. PMID: 11775462 Review. No abstract available.
10th Biennial Helene Harris Memorial Trust meeting.
Balkwill FR, Ashworth A, Bast RC, Berek JS, Boyd J, Disis ML, Gabra H, Gore ME, Hamilton TC, Jacobs IJ, Kaye SB, Kohn EC, Mills GB, Urban ND. Balkwill FR, et al. Among authors: mills gb. Cancer Res. 2006 Mar 15;66(6):2904-6. doi: 10.1158/0008-5472.CAN-05-2093. Cancer Res. 2006. PMID: 16540635 Free article.
Specific keynote: molecular therapeutics in ovarian cancer.
Mills GB, Fang X, Lu Y, Hasegawa Y, Eder A, Tanyi J, Tabassam FH, Mao M, Wang H, Cheng KW, Nakayama Y, Kuo W, Erickson J, Gershenson D, Kohn EC, Jaffe R, Bast RC Jr, Gray J. Mills GB, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S88-92; discussion S93-6. doi: 10.1006/gyno.2002.6692. Gynecol Oncol. 2003. PMID: 12586094 Review. No abstract available.
1,152 results